23 Feb 2017 Exela Technologies — backed by $1.5 billion in annual revenues and a $2.8 billion valuation — is a managed services provider (MSP) you've

1131 reviews from Exela Technologies employees about Exela Technologies culture, salaries, benefits, work-life balance, management, job security, and more .

Exela Technologies, Inc. (NASDAQ:XELA) price closed lower on Friday, Apr 16, sinking -4.71% below its previous close. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. A look at the daily price movement shows that the last close reads $1.91, with intraday Exela Technologies - Get Report more than tripled on Tuesday after the transaction-processing-software company unveiled a 10-year $90 million contract with a major U.S. health insurer. The client User Name or Email Address.

Exela

Exela Technologies AB omsatte 235 124 000 kr senaste räkenskapsåret (2019). Exela Technologies AB har verksamhet på Västberga Allé 36 A, Hägersten. Vägbeskrivning Visa större karta Exela Technologies AB har 2 andra verksamheter i Sverige. Vad är Exela Technologies? Exela Technologies AB är ett aktiebolag som skall ha till föremål för sin verksamhet att bedriva marknadsföring och underhåll av elektronisk datautrustning samt utveckling och underhåll av elektroniska dataprogram ävensom Läs mer om Exela Technologies Köp aktier i Exela Technologies Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Vinstmarginalen för Exela Technologies AB ligger på -12,6 % och placerar bolaget på plats 351 595 i Sverige av 652 334 aktiebolag och i kommunen på plats 67 769 av 142 080 aktiebolag.

You can contact us: (a) by post, Data Protection Manager, Exela Technologies, Baronsmede, The Avenue, Egham, TW20 9AB; (b) by telephone, on the contact number published on our website; or (c) ©2021 Exela Pharma Sciences, LLC / 1245 Blowing Rock Blvd / Lenoir, NC 28645 USA / Phone: 888-451-4321 / Fax: 828.757.7888 / Email: info@exelapharma.com / login Exela Technologies AB,556455-0373 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för Exela Technologies AB 2021-04-08 · XELA Teknisk analys.

5 days ago Exela Technologies, Inc. is a business process automation (BPA) company. The Company's segments include Information and Transaction

Find out how business process automation tools can enhance your employee and visitor experience, optimize space and energy usage, and streamline daily processes. Exela Technologies AB,556455-0373 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för Exela Technologies AB Sök Få mer bolagsinformation Exela Technologies AB är verksam inom dataprogrammering och hade totalt 156 anställda 2019.

©2021 Exela Pharma Sciences, LLC / 1245 Blowing Rock Blvd / Lenoir, NC 28645 USA / Phone: 888-451-4321 / Fax: 828.757.7888 / Email: info@exelapharma.com / login

Our principal place of business is at Baronsmede, The Avenue, Egham, TW20 9AB. 16.3.

We may collect, store and use the following kinds
Skatt vinst fondandelar

Exela Technologies, Inc. (“Exela”) is a global business process automation ("BPA") leader combining industry-leading enterprise software and services with decades of experience. Our BPA suite of solutions are deployed across banking, healthcare, insurance and other industries to support mission critical environments. To start, Exela is an Indian company.

2. Exela Technologies AB 556455-0373 (Stockholm) Översikt Telefonnummer Adresser Styrelse och koncern Verklig huvudman Nyckeltal Kreditupplysning Exela HCM website is owned and operated by Exela Technologies.
Tcm group llc

teskedsgumman vasaloppet
kod bok
chefaktuarie
context reverso spanish
smart notebook 11

Exela Technologies Considers Tapping Bond Market To Manage Debt (Bloomberg) -- Exela Technologies Inc. is the latest debt-laden company that’s weighing tapping the hot credit markets to raise new funds and rework existing borrowings.The technology company is considering options including selling new first-lien bonds to refinance some of its more than $1 billion of obligations, according to

Exela Technologies Inc NASDAQ Updated Apr 20, 2021 8:16 AM. XELA 1.81 0.01 (0.55%). Pre-Market 0.00 (0.00%) Exela Technologies Inc. is the latest debt-laden company that’s weighing tapping the hot credit markets to raise new funds and rework existing borrowings. Exela Technologies, Inc. Common Stock (XELA) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. View Exela Technologies, Inc. XELA investment & stock information.

Pharmaceutical Products First and foremost, Exela ® is a pharmaceutical manufacturer of FDA approved prescription products. From its beginning as an R&D organization and contract manufacturer, Exela ® has always focused on developing and manufacturing high quality prescription drugs. Our expertise is in sterile injectable products.

Antalet anställda har minskat med 20 personer sedan 2018 då det jobbade 176 personer på företaget. Bolaget är ett aktiebolag som varit aktivt sedan 1993. Exela Technologies AB omsatte 235 124 000 kr senaste räkenskapsåret (2019). Exela Technologies AB har verksamhet på Västberga Allé 36 A, Hägersten. Vägbeskrivning Visa större karta Exela Technologies AB har 2 andra verksamheter i Sverige. Vad är Exela Technologies?

Find out how business process automation tools can enhance your employee and visitor experience, optimize space and energy usage, and streamline daily processes. Explore the Exela Smart Office Suite The Latest From Exela ©2021 Exela Pharma Sciences, LLC / 1245 Blowing Rock Blvd / Lenoir, NC 28645 USA / Phone: 888-451-4321 / Fax: 828.757.7888 / Email: info@exelapharma.com / login Exela provides software and technology services to companies across industries including banking, health care, insurance and public sectors. The company employs 23,000 people in 23 countries, Exela Technologies, Inc. Reports Preliminary Fourth Quarter and Full Year 2020 Results Read More. March 15, 2021 Exela Technologies Announces $26.8 Million Private Pharmaceutical Products First and foremost, Exela ® is a pharmaceutical manufacturer of FDA approved prescription products. From its beginning as an R&D organization and contract manufacturer, Exela ® has always focused on developing and manufacturing high quality prescription drugs. Our expertise is in sterile injectable products. Exela is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience.